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Ovarian cancer is associated with the highest mortality
rate of all gynaecologic malignancies, and is identified as
the sixth most common cause of cancer death for Aus-
tralian women. Genomic copy number amplification is a
hallmark of oncogene associated tumour development
and progression. The targeted increase in copy number
of such chromosomal regions has a significant impact
upon gene expression that imparts selective advantages
on cancer cells. These over-expressed genes are
attractive therapeutic targets, particularly as increased
gene expression within the cancer genome is often asso-
ciated with ‘oncogene addiction’.
To identify amplicon targets we have adopted a metho-
dology that combines genomic copy number and expres-
sion data with RNA interference (RNAi) to identify
amplified genes that are functionally relevant. According
to our analysis of SNP array data over 46 Mb of the gen-
ome was amplified as a high level in 10% or more
tumours, encompassing ~300 genes. This set of candidate
genes will be functionally assessed in vitro using a bou-
tique siRNA library to interogate phenotypic alterations in
proliferation and morphology. We have utilized SNP6.0
array data from 39 ovarian cell lines to identify 18 cell
lines that recapitulate the gene amplifications observed in
clinical specimens, which form the basis of this study.
Data obtained from the first cell lines examined indi-
cates that despite the different genetic backgrounds of the
cell lines used, there is overlap in the genes that cause sig-
nificant alterations to cellular proliferation. Furthermore, a
number of genes not previously associated with ovarian
cancer have been shown to impart functional effects
directly associated with genomic amplification. This data
provides evidence that the high-throughput nature of this
functional screen will rapidly identify candidate genes that
may then be streamlined to a validation phase. The identi-
fication and validation of such genes is critical to their
translation as potential therapeutic targets.
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